2013 Fiscal Year Final Research Report
Development of new gene therapy for chronic granulomatous disease using Piggyback transposon
| Project/Area Number |
24791049
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Pediatrics
|
|---|
| Research Institution | Shinshu University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2012-04-01 – 2014-03-31
|
| Keywords | 慢性肉芽腫症 / iPS細胞 / トランスポゾン / PiggyBac / 遺伝子治療 |
|---|
| Research Abstract |
We successfully generated induced pluripotent stem cells (iPSCs) from peripheral T cells of chronic granulomatous disease patient with CYBB gene mutation, using sendai virus vector carrying reprogramming factors OCT3/4, SOX2, KLF4, and c-MYC. In the same way, we generated corrected iPSCs derived from CYBB-transduced T cell using PiggyBac transposon.
We confirmed expression of pluripotency markers (Oct4, SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, Nanog) by immunofluorescence assays. In addition, these iPSCs showed teratoma formation when injected into immunodeficient mice. These colonies could be differentiated to monocytes and neutrophils with AGM-3 stroma cells. Monocytes and neutrophils derived from non-corrected and corrected iPSCs were devoid of oxidase activity by DHR.
These data suggest iPSCs modified by this method were difficult to maintain transgene expression.
|
